| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.CCM.0000045568.12881.10 |
| P698 | PubMed publication ID | 12576937 |
| P50 | author | Greet Van den Berghe | Q41203524 |
| P2093 | author name string | Frank Weekers | |
| Pieter J Wouters | |||
| Roger Bouillon | |||
| Miet Schetz | |||
| Patrick Ferdinande | |||
| Charles Verwaest | |||
| Dirk Vlasselaers | |||
| Peter Lauwers | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Insulin Therapy | Q2002370 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 359-366 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Critical Care Medicine | Q5186605 |
| P1476 | title | Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control | |
| P478 | volume | 31 |
| Q46642910 | 70/30 insulin algorithm versus sliding scale insulin |
| Q33514624 | A benchmark data set for model-based glycemic control in critical care |
| Q46417621 | A blueprint for a sepsis protocol |
| Q41595249 | A comparative assessment of the glucose monitor (SD Codefree) and auto analyzer (BT-3000) in measuring blood glucose concentration among diabetic patients |
| Q44682648 | A multiple logistic regression analysis of in-hospital factors related to survival at six months in patients resuscitated from out-of-hospital ventricular fibrillation |
| Q38414840 | A one-step colorimetric acid-base titration sensor using a complementary color changing coordination system. |
| Q36603212 | A practical approach to hyperglycemia management in the intensive care unit: evaluation of an intensive insulin infusion protocol. |
| Q33293869 | A randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE" (neonatal insulin replacement therapy in Europe) |
| Q33267162 | A review of the use of insulin protocols to maintain normoglycaemia in high dependency patients |
| Q37327600 | A systematic review on quality indicators for tight glycaemic control in critically ill patients: need for an unambiguous indicator reference subset |
| Q42264097 | Abdominal surgical site infections: a prospective study of determinant factors in Harare, Zimbabwe |
| Q43156953 | Accuracy of different methods for blood glucose measurement in critically ill patients |
| Q45302000 | Achieving durable glucose control in the intensive care unit without hypoglycaemia: a new practical IV insulin protocol |
| Q35548943 | Acquired Neuromuscular Disorders in the Intensive Care Unit |
| Q35993115 | Acute hyperglycaemia: a 'new' risk factor during myocardial infarction |
| Q33647910 | Acute hyperglycemia worsens hepatic ischemia/reperfusion injury in rats |
| Q79751936 | Acute liver failure |
| Q35916318 | Acute renal failure is not a "cute" renal failure! |
| Q64132601 | Advances in sepsis treatment |
| Q30437974 | An electronic protocol for translation of research results to clinical practice: a preliminary report |
| Q44901303 | An insulin infusion protocol in critically ill cardiothoracic surgery patients |
| Q41610910 | An interdepartmental collaboration to improve preoperative glycemic control |
| Q37813868 | Analytic review: glucose controversies in the ICU. |
| Q50067550 | Anti-TNF-α antibody alleviates insulin resistance in rats with sepsis-induced stress hyperglycemia |
| Q31059743 | Aortic arch atheroma: stroke reduction in cardiac surgical patients |
| Q34295344 | Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence |
| Q35651504 | Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality--Part 2: Practical aspects and side effects |
| Q37219249 | Assessing the performance of handheld glucose testing for critical care |
| Q37339063 | Assessment of Blood Glucose and Electrolytes during Cardiopulmonary Bypass in Diabetic and Non-Diabetic Patients of Pakistan |
| Q42343494 | Bariatric surgery, exercise, and inpatient glycemia treatment: the American Diabetes Association's 57th Annual Advanced Postgraduate Course |
| Q36390908 | Barriers to glucose control in the intensive care unit |
| Q37623067 | Bench-to-bedside review: Beta-adrenergic modulation in sepsis. |
| Q36955190 | Bench-to-bedside review: metabolism and nutrition. |
| Q37945407 | Bench-to-bedside review: sepsis - from the redox point of view |
| Q64075170 | Benefits of Fasting Abbreviation with Carbohydrates and Omega-3 Infusion During CABG: a Double-Blind Controlled Randomized Trial |
| Q92759799 | Blood Glucose Control and Opportunities for Clinical Pharmacists in Infectious Diseases Ward |
| Q24618730 | Burns: an update on current pharmacotherapy |
| Q37667928 | Carbohydrates - Guidelines on Parenteral Nutrition, Chapter 5. |
| Q42123172 | Change in the perioperative blood glucose and blood lactate levels of non-diabetic patients undergoing coronary bypass surgery |
| Q96953417 | Changes in Myocardial Metabolism Preceding Sudden Cardiac Death |
| Q35539676 | Clinical Trial Design and Outcomes in Patients with Severe Sepsis |
| Q37453093 | Clinical need for continuous glucose monitoring in the hospital |
| Q35091905 | Clinical potential of insulin therapy in critically ill patients |
| Q33750033 | Clinical review: Glucose control in severely burned patients - current best practice |
| Q43138882 | Combining enteral with parenteral nutrition to improve postoperative glucose control |
| Q33295460 | Comparison of a nurse initiated insulin infusion protocol for intensive insulin therapy between adult surgical trauma, medical and coronary care intensive care patients |
| Q37106598 | Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes |
| Q30718380 | Complexity of continuous glucose monitoring data in critically ill patients: continuous glucose monitoring devices, sensor locations, and detrended fluctuation analysis methods |
| Q34001092 | Continuous glucose monitoring for diagnosis and treatment of neonatal hypoglycemia |
| Q46952469 | Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. |
| Q37541645 | Critical illness polyneuropathy and myopathy in the intensive care unit |
| Q35966274 | Delivering obstetrical critical care in developing nations |
| Q36335630 | Design and rationale of safe pediatric euglycemia after cardiac surgery: a randomized controlled trial of tight glycemic control after pediatric cardiac surgery |
| Q86847284 | Diabetes and hyperglycemia in the critical care setting: has the evidence for glycemic control vanished? (Or … is going away?) |
| Q44701916 | Diabetic coma. Management of diabetic ketoacidosis and nonketotic hyperosmolar coma |
| Q36349974 | Does continuous insulin infusion improve glycaemic control and nutrition in hyperglycaemic very low birth weight infants? |
| Q36192387 | Donor care before pancreatic tissue transplantation |
| Q44850027 | Duration of time on intensive insulin therapy predicts severe hypoglycemia in the surgically critically ill population |
| Q45837435 | Early hypoglycaemia and hyperglycaemia and 'tight' glycaemic control with and without glucose infusions. |
| Q33978580 | Early physiologic responses to hemorrhagic hypotension |
| Q24801340 | Early postoperative hyperglycaemia is not a risk factor for infectious complications and prolonged in-hospital stay in patients undergoing oesophagectomy: a retrospective analysis of a prospective trial |
| Q92991715 | Early prediction of extubation failure in patients with severe pneumonia: a retrospective cohort study |
| Q42164798 | Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial |
| Q51002816 | Effect of perioperative intensive insulin therapy for liver dysfunction after hepatic resection. |
| Q54351213 | Effective glycaemic control critically determines insulin cardioprotection against ischaemia/reperfusion injury in anaesthetized dogs. |
| Q37250479 | Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage |
| Q37878336 | Effective glycemic management in hospitalized patients: a multidisciplinary approach. |
| Q36305509 | Elderly patients may benefit from tight glucose control |
| Q33919314 | Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial |
| Q36576950 | Endocrine aspects of acute and prolonged critical illness |
| Q35740551 | Endocrine changes in critical illness |
| Q36818082 | Etiology and effect on outcomes of hyperglycemia in hospitalized patients |
| Q37027809 | Evaluation of a model for glycemic prediction in critically ill surgical patients. |
| Q43777792 | Evaluation of glycemic control metrics for intensive care unit populations. |
| Q45829043 | Evaluation of intensive insulin therapy |
| Q37037213 | Evaluation of point-of-care glucose testing accuracy using locally-smoothed median absolute difference curves |
| Q37407930 | Evaluation of the VIA Blood Chemistry Monitor for Glucose in Healthy and Diabetic Volunteers |
| Q91912282 | Evidence-Based Support for Nutrition Therapy in Head and Neck Cancer |
| Q38245252 | Experimental and clinical evidences for glucose control in intensive care: is infused glucose the key point for study interpretation? |
| Q80152130 | Failure to achieve glycemic control despite intensive insulin therapy in a medical ICU: incidence and influence on ICU mortality |
| Q46434501 | Fungal sepsis--therapeutical strategy |
| Q40329834 | Future perspective: getting GRIP on intensive insulin therapy in acute myocardial infarction |
| Q36842449 | Gastric feed intolerance is not increased in critically ill patients with type II diabetes mellitus |
| Q48632226 | Genetics of postoperative complications following thoracic surgery. |
| Q37635820 | Glucose control and its implications for the general surgeon. |
| Q37134518 | Glucose control during acute myocardial infarction |
| Q30452738 | Glucose control in the intensive care unit: a nutrition support perspective |
| Q36885113 | Glucose control in the intensive care unit: how it is done |
| Q37334028 | Glucose dysmetabolism and prognosis in critical illness |
| Q45165515 | Glucose in parenteral nutrition: a survey of U.S. medical centers |
| Q46690970 | Glucose/insulin infusions in the treatment of subarachnoid haemorrhage: a feasibility study |
| Q39885755 | Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study. |
| Q37762321 | Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options. |
| Q57245151 | Glycaemic control in trauma patients, is there a role? |
| Q42046504 | Glycemia prediction in critically ill patients using an adaptive modeling approach |
| Q43207805 | Glycemic control in critically ill patients before and after institution of an intensive insulin infusion protocol: circadian rhythm and the quality duration calculator |
| Q37640683 | Glycemic control in critically ill patients. |
| Q37032717 | Glycemic control in non-diabetic critically ill patients |
| Q46245031 | Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: stage II of a randomized, controlled multicenter trial |
| Q58101177 | Glycemic control with a basal-bolus insulin protocol in hospitalized diabetic patients treated with glucocorticoids: a retrospective cohort study |
| Q36641951 | Glycemic penalty index for adequately assessing and comparing different blood glucose control algorithms |
| Q36241566 | Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting. |
| Q34392352 | Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes |
| Q80313278 | Hospital protocols for targeted glycemic control: Development, implementation, and models for cost justification |
| Q35936472 | How does blood glucose control with insulin save lives in intensive care? |
| Q24791322 | How to compare adequacy of algorithms to control blood glucose in the intensive care unit? |
| Q46657402 | Hyperglycaemia and mortality of diabetic patients with candidaemia |
| Q55429937 | Hyperglycaemia and mortality. |
| Q43181353 | Hyperglycaemia at admission in acute coronary syndrome patients: prognostic value in diabetics and non-diabetics |
| Q24791110 | Hyperglycaemic index as a tool to assess glucose control: a retrospective study |
| Q38704977 | Hyperglycemia and Acute Kidney Injury During the Perioperative Period |
| Q44478640 | Hyperglycemia and acute illness |
| Q36460003 | Hyperglycemia during critical illness |
| Q57245081 | Hyperglycemia in the Surgical Intensive Care Unit |
| Q34002421 | Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis |
| Q45964649 | Hyperglycemic kidney damage in an animal model of prolonged critical illness. |
| Q35880929 | Hyperinsulinemic Normoglycemia Does Not Meaningfully Improve Myocardial Performance during Cardiac Surgery: A Randomized Trial |
| Q83940196 | Hypoglycaemia: the limiting factor in the glycaemic management of the critically ill? |
| Q33841461 | Hypoglycemia is associated with increased postburn morbidity and mortality in pediatric patients |
| Q50355355 | Impact of early mobilization on glycemic control and ICU-acquired weakness in critically ill patients who are mechanically ventilated |
| Q83469016 | Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI |
| Q46822115 | Impact of postoperative hyperglycemia following surgical repair of congenital cardiac defects |
| Q89205244 | Impact of serum glucose levels on disease severity and outcome in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis |
| Q34760071 | Impact of the insulin and glucose content of the postoperative fluid on the outcome after pediatric cardiac surgery |
| Q42757198 | Impairment of cardiac autonomic nervous system and incidence of arrhythmias in severe hyperglycemia |
| Q36749096 | Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change |
| Q34399092 | Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program |
| Q28217902 | Improved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission |
| Q42598638 | Improvement in glycemic control and outcome corresponding to intensive insulin therapy protocol development |
| Q43047787 | In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes |
| Q37404562 | Increases in whole blood glucose measurements using optically based self-monitoring of blood glucose analyzers due to extreme Canadian winters |
| Q37742952 | Induced hypothermia for trauma: current research and practice |
| Q47219696 | Inflammation-mediated muscle metabolic dysregulation local and remote to the site of major abdominal surgery. |
| Q46620050 | Inflammatory response during hyperglycemia and hyperinsulinemia in a porcine endotoxemic model: the contribution of essential organs |
| Q39268608 | Influence of Glycemic Control on Endogenous Circulating Ketone Concentrations in Adults Following Traumatic Brain Injury |
| Q79449713 | Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome |
| Q35907233 | Inpatient management of hospitalized patients with type 2 diabetes |
| Q24800834 | Insulin and metabolic substrates during human sepsis |
| Q40244959 | Insulin decreases inflammatory signal transcription factor expression in primary human liver cells after LPS challenge |
| Q88871989 | Insulin dependent and independent normalization of blood glucose levels reduces the enhanced rewarding effects of nicotine in a rodent model of diabetes |
| Q36675392 | Insulin infusion therapy for myocardial infarction |
| Q33636556 | Insulin modulates the inflammatory granulocyte response to streptococci via phosphatidylinositol 3-kinase. |
| Q45925632 | Insulin resistance despite tight glucose control is associated with mortality in critically ill surgical patients. |
| Q37241722 | Insulin resistance postburn: underlying mechanisms and current therapeutic strategies |
| Q35151338 | Insulin therapy for the critically ill patient |
| Q46880889 | Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l |
| Q64980899 | Insulin therapy is not associated with improved clinical outcomes in critically ill infants with stress hyperglycemia. |
| Q57245133 | Insulin, glucose control and multiple organ dysfunction syndrome |
| Q46371338 | Insulin: cardiovascular effects and therapeutic applications |
| Q35352652 | Intensive care management of critically sick diabetic patients |
| Q80442389 | Intensive care unit management of patients with stroke |
| Q46158158 | Intensive glucose control after allogeneic hematopoietic stem cell transplantation: a retrospective matched-cohort study |
| Q33321943 | Intensive insulin therapy and mortality in critically ill patients |
| Q34480775 | Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630]. |
| Q37789585 | Intensive insulin therapy during cardiovascular surgery |
| Q33203601 | Intensive insulin therapy for critically ill patients |
| Q57245227 | Intensive insulin therapy in the ICU—reconciling the evidence |
| Q41621936 | Intensive insulin therapy to maintain normoglycemia after cardiac surgery. |
| Q44383136 | Intensive insulin therapy versus conventional glycemic control in patients with acute neurological injury: a prospective controlled trial |
| Q46459980 | Intensive insulin therapy: enhanced Model Predictive Control algorithm versus standard care |
| Q37667914 | Intensive medicine - Guidelines on Parenteral Nutrition, Chapter 14 |
| Q33653311 | Intensive versus conventional insulin therapy in critically ill neurologic patients. |
| Q46906991 | Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients |
| Q36434040 | Is it time for implementation of tight glycaemia control by intensive insulin therapy in every ICU? |
| Q39980377 | Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy? |
| Q48223911 | Local anesthesia: a strategy for reducing surgical site infections? |
| Q35585233 | Management of Severe Sepsis: Integration of Multiple Pharmacologic Interventions |
| Q42008824 | Management of children with diabetes requiring surgery |
| Q52590908 | Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy. |
| Q46943648 | Mean glucose level is not an independent risk factor for mortality in mixed ICU patients |
| Q45009183 | Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-alpha |
| Q43211354 | Metabolic effects of intensive insulin therapy in critically ill patients |
| Q64890004 | Model-based glycemic control in a Malaysian intensive care unit: performance and safety study. |
| Q36925816 | Moderate glucose control results in less negative nitrogen balances in medical intensive care unit patients: a randomized, controlled study |
| Q42577172 | Molecular mechanisms of hyperglycemia and cardiovascular-related events in critically ill patients: rationale for the clinical benefits of insulin therapy |
| Q35918407 | Multicenter Observational Study of the First-Generation Intravenous Blood Glucose Monitoring System in Hospitalized Patients |
| Q30437981 | Multicenter validation of a computer-based clinical decision support tool for glucose control in adult and pediatric intensive care units |
| Q27347641 | Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance |
| Q48337800 | NAFLD and Insulin Resistance Do Not Increase the Risk of Postoperative Complications Among Patients Undergoing Bariatric Surgery—A Prospective Analysis |
| Q46845084 | Neuromuscular abnormalities in critical illness |
| Q33291172 | Neuromuscular dysfunction acquired in critical illness: a systematic review |
| Q44046058 | Neutral protamine hagedorn/regular insulin in the treatment of inpatient hyperglycemia: Comparison of 3 basal-bolus regimens |
| Q35542879 | New treatment strategies for severe sepsis and septic shock |
| Q46840113 | No, the glycaemic target in the critically ill should not be < or = 6.1 mmol/l |
| Q37292173 | Nutrition support challenges in hematopoietic stem cell transplant patients |
| Q80319594 | Nutritional support in acute pancreatitis |
| Q37985388 | Nutritional treatment a various clinical setting--practical considerations |
| Q44967779 | Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients |
| Q38032562 | On the management of hyperglycaemia in critically ill patients undergoing surgery |
| Q36371673 | Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness |
| Q37016581 | Outcomes research in specialized nutrition support |
| Q42597934 | Overview of glycemic control in critical care: relating performance and clinical results |
| Q38869018 | Parenteral Nutrition and Infection Risk in the Intensive Care Unit: A Practical Guide for the Bedside Clinician |
| Q42931757 | Parenteral feeding and intensive insulin therapy |
| Q37626450 | Parenteral glucose and glucose control in the critically ill: a kinetic appraisal |
| Q37481645 | Parenteral nutrition in patients with renal failure - Guidelines on Parenteral Nutrition, Chapter 17. |
| Q33978278 | Parenteral nutrition: Revisited |
| Q39780640 | Patient-level glucose reporting: averages, episodes, or something in between? |
| Q64131272 | Patología neuromuscular en cuidados intensivos |
| Q50179688 | Perioperative Management of Hyperglycemia and Diabetes in Cardiac Surgery Patients |
| Q37831831 | Perioperative glucose control: living in uncertain times--Continuing Professional Development |
| Q24200372 | Perioperative glycaemic control for diabetic patients undergoing surgery |
| Q34611450 | Perioperative insulin therapy using a closed-loop artificial endocrine pancreas after hepatic resection |
| Q44804213 | Physiopathology of severe sepsis |
| Q36605843 | Pilot study of the SPRINT glycemic control protocol in a Hungarian medical intensive care unit |
| Q36410043 | Pituitary function during severe and life-threatening illnesses. |
| Q51496846 | Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. |
| Q79102815 | Position of the American Dietetic Association: Integration of medical nutrition therapy and pharmacotherapy |
| Q42339422 | Potential beneficial mechanisms of insulin (glucose-potassium) in acute myocardial infarction |
| Q37043548 | Practical pharmacologic aspects of therapeutic hypothermia after cardiac arrest. |
| Q46896951 | Prediction and Outcome of Intensive Care Unit-Acquired Paresis |
| Q44611562 | Predictors of intensive care unit admission and related outcome for patients after pancreaticoduodenectomy |
| Q46457551 | Pretreatment with intravenous ascorbic acid preserves endothelial function during acute hyperglycaemia (R1). |
| Q34016041 | Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery |
| Q36824466 | Principles and strategies for monitoring home parenteral nutrition |
| Q37590782 | Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress |
| Q42013683 | Prognostic indexes of septic syndrome in the emergency department |
| Q43517161 | Prospective operationalization and feasibility of a glycemic control protocol in critically ill children* |
| Q45216673 | Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients |
| Q44846607 | Protective effects of ascorbic acid on arterial hemodynamics during acute hyperglycemia |
| Q37797332 | Real-time glucose monitoring in the hospital: future or now? |
| Q37453086 | Reducing glycemic variability in intensive care unit patients: a new therapeutic target? |
| Q36188318 | Relationship between hyperglycemia and infection in critically ill patients |
| Q50792505 | Rush University guidelines and protocols for the management of hyperglycemia in hospitalized patients: elimination of the sliding scale and improvement of glycemic control throughout the hospital. |
| Q46817022 | Safety and efficacy of an intensive insulin protocol in a burn-trauma intensive care unit |
| Q37070147 | Safety and efficacy of continuous insulin infusion in noncritical care settings |
| Q55020164 | Selection of quality indicators for nutritional therapy in pediatrics: a cross-sectional study conducted in Brazil. |
| Q39247164 | Sepsis and Septic Shock: Current Treatment Strategies and New Approaches. |
| Q36995847 | Sepsis: a clinical update. |
| Q38207461 | Should guidelines for glycemic control of the critically ill be individualized?: Weighing the evidence from randomized and observational investigations |
| Q44883798 | Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults |
| Q37036416 | Standards of medical care in diabetes--2009. |
| Q36885107 | Strategies to improve ingestive behaviour with reference to critical illness |
| Q37493834 | Stress hyperglycaemia |
| Q35678350 | Stress-hyperglycemia, insulin and immunomodulation in sepsis |
| Q47395126 | Strict blood glucose control by an artificial endocrine pancreas during hepatectomy may prevent postoperative acute kidney injury |
| Q43276193 | Surgical intensive care medicine. Current therapy concepts for septic diseases |
| Q46252162 | Surgical site infections following colorectal surgery in patients with diabetes: association with postoperative hyperglycemia |
| Q64126988 | Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock |
| Q42287985 | The "state of the nation" in trauma critical care: Where are we? |
| Q39529177 | The Contractility of Isolated Rat Atrial Tissue during Hypoxia is Better Preserved in a High- or Zero-Glucose Environment than in a Normal Glucose Environment |
| Q42257534 | The Surviving Sepsis Campaign sepsis change bundles and clinical practice |
| Q64236215 | The association of intravenous insulin and glucose infusion with intensive care unit and hospital mortality: a retrospective study |
| Q39144663 | The biochemical alterations underlying post-burn hypermetabolism |
| Q37763876 | The effect of Baihu Decoction (白虎汤) on blood glucose levels in treating systemic inflammatory response syndrome |
| Q44083246 | The effect of hyperglycemia on neonatal immune responses in-vitro |
| Q30373754 | The effect of perioperative insulin treatment on cardiodepression in mild adiposity in mice. |
| Q48785226 | The effects of a randomised multi-centre trial and international accreditation on availability and quality of clinical guidelines |
| Q46656491 | The impact of a normoglycemic management protocol on clinical outcomes in the trauma intensive care unit |
| Q36449389 | The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery |
| Q37279886 | The impact of early hypoglycemia and blood glucose variability on outcome in critical illness |
| Q36680807 | The importance of insulin administration in the critical care unit |
| Q36603188 | The intraoperative glycemic response to intravenous insulin during noncardiac surgery: a subanalysis of the DeLiT randomized trial |
| Q36335155 | The links between diabetes and cardiovascular disease |
| Q46606078 | The modulatory effect of lipids and glucose on the neonatal immune response induced by Staphylococcus epidermidis |
| Q43081779 | The new Surviving Sepsis Campaign recommendations on glucose control should be reconsidered |
| Q36297527 | The pharmacologic modulation of the hypermetabolic response to burns |
| Q36813092 | The postoperative care of adult patients exposed to deep hypothermic circulatory arrest |
| Q46971627 | The relationship between blood glucose control and intolerance to enteral feeding during critical illness |
| Q35544749 | The role of body mass index and diabetes in the development of acute organ failure and subsequent mortality in an observational cohort |
| Q37510565 | The role of hyperglycemia in burned patients: evidence-based studies |
| Q35600806 | The roles of insulin and hyperglycemia in sepsis pathogenesis. |
| Q36742049 | Therapy insight: the effect of tight glycemic control in acute illness |
| Q24801661 | Tight blood glucose control: a recommendation applicable to any critically ill patient? |
| Q42743856 | Tight glycaemic control in acute exacerbations of COPD. |
| Q36392671 | Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol |
| Q37663614 | Tight perioperative glycemic control using an artificial endocrine pancreas |
| Q84644799 | Timing of insulin therapy affects the inflammatory response in endotoxemic rats |
| Q36286307 | Transient hyperglycaemia - an underestimated problem of paediatric oncohaematology. |
| Q30978193 | Using Continuous Glucose Monitoring Data and Detrended Fluctuation Analysis to Determine Patient Condition: A Review |
| Q36399253 | Using the high-dose corticotropin test to diagnose relative adrenal insufficiency in vasopressor-dependent septic shock. |
| Q39714197 | Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients |
| Q44461689 | Variability of blood glucose concentration and short-term mortality in critically ill patient |
| Q33338424 | Why are clinicians not embracing the results from pivotal clinical trials in severe sepsis? A bayesian analysis |
| Q83105672 | [Diabetes and heart transplantation] |
| Q40482818 | [Multicenter study on the prevalence of hyperglycemia among hospitalized patients with parenteral nutrition]. |
| Q84564048 | [Peri-operative adjustment and treatment of diabetes mellitus] |
| Q81039097 | [Preoperative long-term therapy] |
| Q80305414 | [Prevention and therapy of acute renal failure: the importance of metabolic intervention] |
| Q75198775 | [Progress in therapy of infection] |
| Q45938559 | [Repercussions and management of perioperative hyperglycemia in cardiac surgery] |
| Q75356546 | [Role of the innate immune response in sepsis] |
| Q81484333 | [Therapy of organ failure in primary extracardiac diseases] |
| Q81542419 | [Urosepsis. Current therapy and diagnosis] |
| Q26829973 | 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat |
Search more.